Fitting a neural prosthesis using impedance and electrode height
12 claims: 2 independent, 10 dependent
- 1A retinal prosthesis comprising:a plurality of electrodes (10) suitable to stimulate neural tissue;and characterized in that the retinal prosthesis comprises at least one of: a) means for measuring impedance of the electrode retinal interface of at least one of said plurality of electrodes (10);and b) means for measuring the height from the retinal surface of at least one of said plurality of electrodes (10);and further comprises means for estimating a threshold of perception based on a respective one of said measured impedance or said height from the retinal surface.
- 6The retinal prosthesis according to any one of the preceding claims, comprising means for measuring the height from the retinal surface of at least one of said plurality of electrodes (10), wherein said means for measuring the height from the retinal surface is optical coherence tomography.
Independent claims3
95 paragraphs in 2 sections, as filed
<u>Field of the Invention</u>
0001The present invention is generally directed to neural stimulation and more specifically to an improved method of optimizing neural stimulation levels for artificial vision.
<u>Background of the invention</u>
0002In 1755 LeRoy passed the electrical discharge of a Leyden jar through the eye orbit of a man who was blind from cataracts and the subject saw "flames passing rapidly downwards." Ever since, there has been a fascination with electrically elicited visual perception. The general concept of electrical stimulation of retinal cells to produce these flashes of light or phosphenes has been known for quite some time. Based on these general principles, some early attempts at devising a prosthesis for aiding the visually impaired have included attaching electrodes to the head or eyelids of subjects. While some of these early attempts met with some limited success, these early prosthetic devices were large, bulky and could not produce adequate simulated vision to truly aid the visually impaired.
0003In the early 1930's, Foerster investigated the effect of electrically stimulating the exposed occipital pole of one cerebral hemisphere. He found that, when a point at the extreme occipital pole was stimulated, the subject perceived a small spot of light directly in front and motionless (a phosphene). Subsequently, Brindley and Lewin (1968) thoroughly studied electrical stimulation of the human occipital (visual) cortex. By varying the stimulation parameters, these investigators described in detail the location of the phosphenes produced relative to the specific region of the occipital cortex stimulated. These experiments demonstrated: (1) the consistent shape and position of phosphenes; (2) that increased stimulation pulse duration made phosphenes brighter; and (3) that there was no detectable interaction between neighboring electrodes which were as close as 2.4 mm apart.
0004As intraocular surgical techniques have advanced, it has become possible to apply stimulation on small groups and even on individual retinal cells to generate focused phosphenes through devices implanted within the eye itself. This has sparked renewed interest in developing methods and apparatuses to aid the visually impaired. Specifically, great effort has been expended in the area of intraocular retinal prosthesis devices in an effort to restore vision in cases where blindness is caused by photoreceptor degenerative retinal diseases such as retinitis pigmentosa and age related macular degeneration which affect millions of people worldwide.
0005Neural tissue can be artificially stimulated and activated by prosthetic devices that pass pulses of electrical current through electrodes on such a device. The passage of current causes changes in electrical potentials across visual neuronal membranes, which can initiate visual neuron action potentials, which are the means of information transfer in the nervous system.
0006Based on this mechanism, it is possible to input information into the nervous system by coding the information as a sequence of electrical pulses which are relayed to the nervous system via the prosthetic device. In this way, it is possible to provide artificial sensations including vision.
0007One typical application of neural tissue stimulation is in the rehabilitation of the blind. Some forms of blindness involve selective loss of the light sensitive transducers of the retina. Other retinal neurons remain viable, however, and may be activated in the manner described above by placement of a prosthetic electrode device on the inner (toward the vitreous) retinal surface (epiretinal). This placement must be mechanically stable, minimize the distance between the device electrodes and the visual neurons, and avoid undue compression of the visual neurons.
0008In <patcit id="pcit0001" dnum="US4573481A"><text>1986, Bullara (US Pat. No. 4,573,481</text></patcit>) patented an electrode assembly for surgical implantation on a nerve. The matrix was silicone with embedded iridium electrodes. The assembly fit around a nerve to stimulate it.
0009Dawson and Radtke stimulated cat's retina by direct electrical stimulation of the retinal ganglion cell layer. These experimenters placed nine and then fourteen electrodes upon the inner retinal layer (i.e., primarily the ganglion cell layer) of two cats. Their experiments suggested that electrical stimulation of the retina with 30 to 100 uA current resulted in visual cortical responses. These experiments were carried out with needle-shaped electrodes that penetrated the surface of the retina (see also <patcit id="pcit0002" dnum="US4628933A"><text>US Pat. No. 4,628,933 to Michelson</text></patcit>).
0010The Michelson '933 apparatus includes an array of photosensitive devices on its surface that are connected to a plurality of electrodes positioned on the opposite surface of the device to stimulate the retina. These electrodes are disposed to form an array similar to a "bed of nails" having conductors which impinge directly on the retina to stimulate the retinal cells. <patcit id="pcit0003" dnum="US4837049A"><text>US Patents 4,837,049 to Byers </text></patcit>describes spike electrodes for neural stimulation. Each spike electrode pierces neural tissue for better electrical contact. <patcit id="pcit0004" dnum="US5215088A"><text>US Patent 5,215,088 to Norman </text></patcit>describes an array of spike electrodes for cortical stimulation. Each spike pierces cortical tissue for better electrical contact.
0011The art of implanting an intraocular prosthetic device to electrically stimulate the retina was advanced with the introduction of retinal tacks in retinal surgery. De Juan, et al. at Duke University Eye Center inserted retinal tacks into retinas in an effort to reattach retinas that had detached from the underlying choroid, which is the source of blood supply for the outer retina and thus the photoreceptors. See, e.g.,<nplcit id="ncit0001" npl-type="s"><text> E. de Juan, et al., 99 Am. J. Ophthalmol. 272 (1985</text></nplcit>). These retinal tacks have proved to be biocompatible and remain embedded in the retina, and choroid/sclera, effectively pinning the retina against the choroid and the posterior aspects of the globe. Retinal tacks are one way to attach a retinal array to the retina. <patcit id="pcit0005" dnum="US5109844A"><text>US Patent 5,109,844 to de Juan </text></patcit>describes a flat electrode array placed against the retina for visual stimulation. <patcit id="pcit0006" dnum="US5935155A"><text>US Patent 5,935,155 to Humayun</text></patcit> describes a retinal prosthesis for use with the flat retinal array described in de Juan.
0012In addition to the electrode arrays described above, there are several methods of mapping a high resolution camera image to a lower resolution electrode array. <patcit id="pcit0007" dnum="US6400989B"><text>US Patent 6,400,989 to Eckmiller </text></patcit>describes spatio-temporal filters for controlling patterns of stimulation in an array of electrodes. The assignee of the present applications has three related <patcit id="pcit0008" dnum="US09515373B"><text>US patent applications: 09/515,373, filed February 29, 2000</text></patcit>, entitled Retinal Color Prosthesis for Color Sight Restoration; <patcit id="pcit0009" dnum="US09851268B"><text>09/851,268, filed May 7,2001</text></patcit>. entitled Method, Apparatus and System for Improved Electronic Acuity and Perceived Resolution Using Eye Jitter Like Motion; and Attorney Docket S242-USA, filed on current date herewith, entitled User Directed Pixel Re-Mapping.
0013Each person's response to neural stimulation differs. In the case of retinal stimulation, a person's response varies from one region of the retina to another. In general, the retina is more sensitive closer to the fovea. Responses are also very sensitive to the distance of the electrode array from the retinal surface. Any stimulation with magnitude less than the threshold of perception is ineffective in producing an image. Stimulation beyond a maximum level will be painful and possibly dangerous to the subject. It is therefore, important to map any video image to a range of stimulation values between the minimum and maximum for each individual electrode. With a simple retinal prosthesis, it is possible to adjust the stimulation manually by stimulating and questioning the subject. As resolution (number of electrodes) increases, it is tedious or impossible to adjust each electrode by stimulating and eliciting a subject response.
0014A manual method of fitting or adjusting the stimulation levels of an auditory prosthesis is described in <patcit id="pcit0010" dnum="US4577642A"><text>US patent 4,577,642, Hochmair et al.</text></patcit> Hochmair adjusts the auditory prosthesis by having a user compare a received signal with a visual representation of that signal.
0015A more automated system of adjusting an auditory prosthesis using middle ear reflex and evoked potentials is described in <patcit id="pcit0011" dnum="US6157861A"><text>US patent 6,157,861, Faltys et al.</text></patcit> An alternate method of adjusting an auditory prosthesis using the stapedius muscle is described in <patcit id="pcit0012" dnum="US6205360B"><text>US Patent 6,205,360, Carter et al.</text></patcit> A third alternative using myogenic evoked response is disclosed in <patcit id="pcit0013" dnum="US6415185B"><text>US Patent 6,415,185, Maltan</text></patcit>.
0016<patcit id="pcit0014" dnum="US6208894B"><text>US Patent 6,208,894, Schulman </text></patcit>describes a network of neural stimulators and recorders implanted throughout the body communicating wirelessly with a central control unit. <patcit id="pcit0015" dnum="US6522928B"><text>US Patent 6,522,928, Whitehurst</text></patcit>, describes an improvement on the system described in Schulman using function electro stimulation also know as adaptive delta modulation to communicate between the implanted devices and the central control unit.
0017The greatest dynamic range is achieved by setting the minimum stimulation at the threshold of perception and the maximum stimulation level approaching the pain threshold. It is unpleasant for a subject to first concentrate to detect the minimum perception and then be subjected to stimulation near the threshold of pain.
0018One major concern in the field has been that the amount of electrical charge needed to elicit light percepts might be too high to permit long-term stimulation without damage to the retina. A second concern is that the current required to elicit percepts may fluctuate over time, due to either neurophysiological change or damage to the retina itself, electrochemical changes on the electrode surface, or instability of position of the array on the retinal surface.
0019Previous short-term acute studies (lasting less than 3 hours) found that localized retinal electrical stimulation of blind subjects with RP and AMD resulted in discrete percepts, however the amount of electrical current required to elicit a response was relatively large compared to animal studies examining retinal responses to electrical stimulation. One likely explanation for these high thresholds is that it is extremely difficult to lay an electrode array flush on the retinal surface during an acute trial. However an alternative possibility was that the high electrical thresholds found in human trials were due to the effects of retinal degeneration which include both loss of cells and severe rewiring within the inner layers of the retina.
0020The human retina includes about four million individual photoreceptors. An effective visual prosthesis may include thousands of electrodes. An automated system is needed to adjust individual electrodes in a visual prosthesis for maximum benefit without the need for subject interaction in a long and difficult process. <patcit id="pcit0016" dnum="WO2004052451A1"><text>WO 2004052451 A1</text></patcit> provides a method for determining optimal stimulus pulse widths and amplitudes for stimulating nerves with at least one electrode. <patcit id="pcit0017" dnum="WO2005000394A1"><text>WO 2005000394 A1</text></patcit> provides a test device comprising a trigger electromyographic stimulator. <patcit id="pcit0018" dnum="US5722403A"><text>US 5,722,403</text></patcit> provides a system using a porous electrode for ablating and visualizing interior tissue regions. <patcit id="pcit0019" dnum="US6293674B"><text>US 6,293,674</text></patcit> provides an apparatus for diagnosing and monitoring eye disease.
Summary of the Invention
0021Accordingly, the present invention provides a retinal prosthesis as set out in claim 1. response to electrical neural stimulation varies from subject to subject. Measure of impedance is used to predict the electrode height from the neural tissue and, thereby, predict the threshold of perception. Electrode height is measured directly to predict the threshold of perception.
<u>Brief Description of the Drawings</u>
0022<ul id="ul0001" list-style="none" compact="compact"><li><figref idref="f0001"><b>FIG. 1</b></figref> is a perspective view of the implanted portion of the preferred retinal prosthesis.</li><li><figref idref="f0002"><b>FIG. 2a</b></figref> is a fundus photo showing and electrode array on the retina.</li><li><figref idref="f0002"><b>FIG. 2b</b></figref> is a Cross-sectional OCT image of the retina and electrode array shown in <figref idref="f0002">Fig. 2a</figref>.</li><li><figref idref="f0003"><b>FIG. 3a</b></figref> is a graph showing OCT distance estimate by two observers.</li><li><figref idref="f0003"><b>FIG. 3b</b></figref> is a graph showing OCT retinal thickness estimates by two observers.</li><li><figref idref="f0004"><b>FiG. 4a - f</b></figref> are a set of six bar graphs showing perception threshold measurements in six subjects.</li><li><figref idref="f0005"><b>FIG. 5</b></figref><b>a</b> - <b>c</b> are graphs showing the relationship between electrode diameter and threshold of perception.</li><li><figref idref="f0006"><b>FIG. 6</b></figref><b>a</b> - <b>v</b> are graphs showing the relationship of time to threshold of perception, impedance, electrode height, and retinal thickness.</li><li><figref idref="f0007"><b>FIG. 7</b></figref><b>a -f</b> are graphs showing the correlation of threshold of perception, impedance and retinal thickness.</li><li><figref idref="f0008"><b>FIG. 8</b></figref> depicts a screen showing the preferred method of communicating electrode impedance.</li><li><figref idref="f0009"><b>FIG. 9</b></figref> is a flowchart of the impedance test.</li><li><figref idref="f0010 f0011 f0012"><b>Fig 10</b></figref><b>a - c</b> are a flowchart of the automated impedance measurement and electrode deactivation procedure.</li><li><figref idref="f0013"><b>Fig 11</b></figref> depicts a stimulation pulse further illustrating the measurements described in <figref idref="f0010 f0011 f0012">Fig. 10</figref>.</li></ul>
<u>Detailed Description of the Preferred Embodiments</u>
0023The following description is of the best mode presently contemplated for carrying out the invention. This description is not to be taken in a limiting sense, but is made merely for the purpose of describing the general principles of the invention. The scope of the invention should be determined with reference to the claims.
0024<figref idref="f0001">Figure 1</figref> shows a perspective view of the implanted portion of the preferred retinal prosthesis. A flexible circuit <b>1</b> includes a flexible circuit electrode array <b>10</b> which is mounted by a retinal tack (not shown) or similar means to the epiretinal surface. The flexible circuit electrode array <b>10</b> is electrically coupled by a flexible circuit cable <b>12,</b> which pierces the sclera and is electrically coupled to an electronics package <b>14,</b> external to the sclera.
0025The electronics package <b>14</b> is electrically coupled to a secondary inductive coil <b>16.</b> Preferably the secondary inductive coil <b>16</b> is made from wound wire. Alternatively, the secondary inductive coil <b>16</b> may be made from a flexible circuit polymer sandwich with wire traces deposited between layers of flexible circuit polymer. The electronics package <b>14</b> and secondary inductive coil <b>16</b> are held together by a molded body <b>18.</b> The molded body <b>18</b> may also include suture tabs <b>20.</b> The molded body <b>18</b> narrows to form a strap <b>22</b> which surrounds the sclera and holds the molded body <b>18,</b> secondary inductive coil <b>16,</b> and electronics package <b>14</b> in place. The molded body <b>18,</b> suture tabs <b>20</b> and strap <b>22</b> are preferably an integrated unit made of silicone elastomer. Silicone elastomer can be formed in a precurved shape to match the curvature of a typical sclera. However, silicone remains flexible enough to accommodate implantation and to adapt to variations in the curvature of an individual sclera. The secondary inductive coil <b>16</b> and molded body <b>18</b> are preferably oval shaped. A strap <b>22</b> can better support an oval shaped coil.
0026The preferred prosthesis includes an external portion (not shown) which includes a camera, video processing circuitry and an external coil for sending power and stimulation data to the implanted portion.
0027The electronics package <b>14</b> converts a radio frequency signal into electrical stimulation patterns. Input signals are provided via an inductive wireless link using an external antenna magnetically aligned over the secondary inductive coil 16. The desired pulse pattern is sent to a custom-built video processing unit that codes the data as a serial data stream, and transmits it to the implant via the wireless link. In addition, the transmitted signal supplied power to the implant. A reverse telemetry function in the implant allows direct measurement of impedance of each electrode. The subjects' un-operated eye is patched during all tests to ensure that subjects' thresholds are not affected by residual vision in the un-operated eye. While 1 kHz is used in the preferred embodiment, it should be noted that higher frequencies produce more accurate results. 1 kHz is a compromise between impedance accuracy and hardware complexity. It is further possible to determine impedance by a single biphasic pulse. Pulses may also take various wave forms such as sinusoidal or square wave.
<i>Optical Coherence Tomography (OCT)</i>
0028Optical coherence tomography may be used to measure the distance of the electrode array from the retinal surface and to measure retinal thickness. The underlying principle of OCT imaging is much like that of ultrasound, except that light is used instead of sound, thus permitting measurements resolved to the scale of ≤10µm. Cross-sectional images of retinal tissue across multiple depth planes may be inferred from the profile of near infrared backscattered light.
0029<figref idref="f0002">Figure 2a</figref> shows a fundus image of an intraocular stimulating array with the OCT imaging light source visible <b>56.</b> The arrow <b>58</b> represents the direction along which imaging is carried out. <figref idref="f0002">Figure 2b</figref> shows the image of the cross-section of the retina that lies under the OCT imaging light source of 2a. Broad shadows are cast by the electrodes <b>60,</b> and narrow shadows <b>62</b> are either due to the imaging light source passing across the edge of the electrode (as is the case in electrode 3 in this example) or are cast by individual wires within the array (note that wires also pass above individual electrodes). Corresponding electrodes are labeled across the figure. The small deviation between the fundus and OCT image is due to small eye-movements in the very short time interval that separates acquisition of the two images.
0030As shown in <figref idref="f0002">Figure 2b</figref>, the distance of the electrode array from the retinal surface is defined as the distance from the top of each electrode to the inner surface of the ganglion cell layer arrows <b>64.</b> Measurements therefore include the electrode thickness, which varies between 80-120 µm depending on the exact cross-section of the electrode over which the OCT measurement is taken. The thickness of the retina is defined as the distance from the inner surface of the retinal pigment epithelium to the surface of the internal limiting membrane <b>66.</b>
0031As can be seen in <figref idref="f0002">Figure 2</figref>, it was not always easy to determine the exact position of the top of the electrode, the surface of the internal limiting membrane, or the inner surface of the retinal pigment epithelium, and these judgments relied heavily on the experience of the experimenter. Two experimenters performed these analyses with the help of custom software written in Matlab. Such subjective measures could be automated through computer imaging and image recognition software to make this subjective measure objective.
0032We cross-validated the judgments of these experimenters by having both experimenters analyze the same subset of 43 estimates of electrode distance and retinal thickness. <figref idref="f0003">Figure 3a</figref> plots the first experimenter's judgments of electrode distance from the retinal surface along the x-axis, and the second experimenter's judgments along the y-axis. If two experimenters' judgments were perfectly correlated the data would fall along the dashed line of slope 1. The actual best fitting regression line had a slope of 1.06, as shown by the solid line. A Monte-Carlo procedure in which each judgment was randomly assigned to an experimenter is used to assess whether the best-fitting regression slope for these data differed significantly from 1. Performance across observers was strongly correlated (r<sup>2</sup> = 0.78; p<0.01) and the difference between the best-fitting regression line and a line of slope 1 was not significant (p>0.05, two-tailed).
0033<figref idref="f0003">Figure 3b</figref> plots the first experimenter's judgments of retinal thickness along the x-axis, and the second experimenter's judgments along the y-axis. Once again, if the two experimenters' judgments were perfectly correlated the data would fall along the dashed line of slope 1. The actual best fitting regression line had a slope of 0.83, as shown by the solid line. Once again, performance across observers was strongly correlated (r<sup>2</sup> = 0.85; p<0.01) and a Monte-Carlo procedure demonstrated that the best-fitting regression slope did not differ significantly from 1 (p>0.05, two-tailed).
0034These measurements demonstrate that inter-experimenter differences in measurement between experimenters were small, and are unlikely to result in large errors or biases in estimates of either electrode distance or retinal thickness. The high consistency across experimenters demonstrates that trained observers can make consistent judgments about electrode distance and retinal thickness on the basis of our OCT images.
<i>Impedance</i>
0035Electrode impedance provides a measure of current resistance that is affected by both the electrochemical properties and size of the electrode itself, and the properties of the tissue surrounding the electrode. We can determine, in retinal implants, that impedance is associated with array position on the retinal surface. In particular, impedance is inversely proportional to electrode height. Note that electrode height as used herein refers to the distance between the retinal surface and the electrode.
0036Impedance is measured using software with a back telemetry program. The software uses a same diagnostic function of the implant by sequentially generating a 1 kHz, 10 µA sine wave on each electrode, recording the resulting voltage drop, calculating the impedance modulus in kΩ and transmitting this information from the implant to the external system via a reverse telemetry link. Impedance measurements are taken at the beginning and the end of each stimulating session and may be taken during surgery.
<i>Perceptual thresholds</i>
0037Perceptual thresholds are the amount of current needed to detect a pulse on 50% of trials, corrected for false alarms, i.e. the amount of current needed to elicit visible percepts of light. We can measure detection thresholds for each electrode using a "standard pulse" consisting of a charge-balanced 0.975 ms cathodic pulse followed by a 0.975 ms anodic pulse with a 0.975 ms inter-pulse delay between cathodic and anodic components. All pulse waveforms were biphasic charge balanced.
0038During this period a yes-no procedure was used, with half the trials being blank trials. The stimulation intensity of the test pulse was varied using a three-up-one-down staircase, and each threshold was based on approximately 100 trials (generally 50 trials are adequate to estimate threshold with reasonable accuracy). After November 2004 this procedure was automated, and subjects responded whether or not they saw a stimulus on each trial via key press.
0039We validated that each change in procedure did not lead to a discernable change in estimated thresholds by measuring threshold using both the old and new technique on a number of electrodes before changing our protocol to the new technique.
RESULTS
Thresholds
0040Phosphene appearance near threshold is typically white or yellow, and phosphenes are reported as being round or oval in shape. In these cases an increase in the stimulation current results in subjects seeing a light spot in the same location. Phosphenes at threshold were not uncomfortable or unpleasant.
0041Mean thresholds over the entire period over which we collected data for each subject are shown for each electrode and subject in <figref idref="f0004">Figure 4</figref>. For each subject, electrodes are ordered from least to most sensitive along the x-axis. Gray and black bars represent electrodes with a diameter of 250 and 500µm respectively. Threshold current required for the subject to see a pulse on 50% of trials corrected for false alarms is shown along the y-axis. Note the dramatic change of scale along the y-axis across subjects. Most of the variation in threshold across repeated measurements (single error bars are shown) is due to variation in threshold over time as opposed to measurement error, as illustrated in <figref idref="f0006">Figure 6</figref>; measured thresholds taken within a few days of each other tend to be very close in value.
<i>Thresholds as a function of electrode size</i>
0042Subjects S4-6 were implanted with checkerboard arrays in which electrodes of 250 and 500 µm alternated in the array (see <figref idref="f0002">Figure 2a</figref>). We compared mean threshold between these two electrode sizes for each subject. Other data shown suggest that the distance of the array from the retinal surface has a dramatic effect on thresholds. However, the checkerboard arrangement used in these three subjects provided a way of crudely factoring out the effects of electrode distance, since any variation in the distance of electrodes was likely to average out across the two electrodes sizes. To our surprise, we found that electrode size did not affect current threshold (Two-factor, subject x electrode size, ANOVA, p>0.05 F=0.367), see <figref idref="f0005">Figure 5a</figref>.
0043It has previously been shown within in vitro animal preparations that the log threshold current required to elicit spikes within in vitro retina is linearly correlated with log electrode area. <figref idref="f0005">Figure 5b</figref> compares mean thresholds. It is possible that a wider range of electrode sizes would make threshold differences as a function of electrode size more apparent. It is also possible, given the large electrode sizes used in this experiment that current density is highest in a ring around the electrode edges. Smaller electrodes would be expected to have more even current distribution across the electrode surface.
0044As illustrated in <figref idref="f0005">Figure 5b</figref>, previous human studies, which were mainly carried out in acute preparations, show remarkable variability in threshold. There are multiple potential causes for this variability. Under acute conditions subject concentration and electrode position are difficult to control and it is only possible to collect a small number of trials. Even where data were collected chronically, reported thresholds were based on a small number of trials, and different sizes of electrodes were not implanted within the same subjects, thereby confounding array position and inter-subject variability with electrode size.
0045The data reported here are lower than those reported in previous studies, and demonstrate that the current intensity levels required to elicit percepts in humans are consistent with the current intensities required within in vitro experiments using similar electrode sizes. Our subjects are surprisingly sensitive, given that the criterion used to define threshold used within in vitro studies is current stimulation level will reliably elicit spike in a single cell. However it has been previously shown that subjects with normal vision can reliably detect a single photon of light, suggesting that a very small increase over the baseline firing rate of ganglion cells is probably sufficient to mediate behavioral detection. It is also possible that degenerated human retina is more sensitive to electrical stimulation than the non-degenerate rodent retinal models generally used for in vitro experiments.
<i>Thresholds over time</i>
0046Thresholds do not remain stable over time, as shown in the first column of <figref idref="f0006">Figure 6</figref>. On the whole, subject thresholds tended to increase postoperatively, consistent with the electrode array lifting off the retina. For each subject we calculated the best-fitting linear regression over time across all electrodes. As described above, S2's array separated from the retina after 11 months due to the subject falling and bumping her head and the array was then reattached. For this subject we calculated separate linear regressions for each array attachment.
0047In all subjects except S1 there was a significant tendency for the slopes of the linear regression describing threshold as a function of time for each individual electrode to have a positive slope (two-tailed t-test, p<0.05). For S1 the tendency for slopes to be positive fell just below significance (p=0.057, t =2.061). While reasonably well fit by a linear regression, each subject showed individual patterns of threshold instability overtime. As discussed below, we believe that these changes in threshold are mainly driven by changes in the distance of the electrode array from the retinal surface.
<i>Impendances</i>
0048As would be expected, impedance did vary with electrode size, as shown in <figref idref="f0005">Figure 5c</figref> (Two-factor ANOVA with replication, (p<0.001, F=146.650). After implantation we also see significant variability in impedance over time, as shown in the second column of <figref idref="f0006">Figure 6</figref>. On the whole, subject impedances tended to decrease postoperatively during the weeks and months after implantation, consistent with the electrode array lifting off the retina. These data, together with that from OCT measurements, suggests that for the relatively thick and heavy arrays used in this implantation a single tack was not sufficient to maintain the array in a stable position flush to the retinal surface.
0049For each subject we calculated the best-fitting linear regression over time across all electrodes. For all subjects except S5, the slopes of the linear regressions describing impedance as a function of time for each electrode had a significant tendency to decrease over time (p<0.05). For S5 there was a non-significant tendency for slopes to be negative (p=0.122, t=-1.6416). While reasonably well fit by a linear regression, each subject showed an individual patterns of impedance instability over time. As discussed below, we believe that these changes in impedance are mainly driven by changes in the distance of the electrode array from the retinal surface.
<i>Array Position and Retinal Thickness</i>
0050The two right columns of <figref idref="f0006">Figure 6</figref> show measured distances of the array form the retinal surface and measured retinal thickness respectively. Note that estimates of electrode distance from the retina include the thickness of the electrode (approximately 80-120µm), as described in <i>Methods</i> above. Occasionally there were multiple OCT images of the same electrode taken on the same day. In these cases measurements of electrode distance and retinal thickness for that electrode were averaged and standard errors calculated. Due to the difficulty in collecting these measurements, only a subset of electrodes were measured on any given date. No clear trend over time is visible across subjects for either electrode distance or retinal thickness.
<i>The Relationship between Threshold, Impedance, Electrode distance and Retinal thickness.</i>
0051<figref idref="f0007">Figure 7a-f</figref> shows the relationship between threshold, impedance, electrode distance and retinal thickness. In all cases data are plotted on log-log axes. To find corresponding measurements, we partitioned our data into 30 day time periods. So for example, a given data point comparing impedance and threshold values might represent the average across several impedance measurements and several threshold measurements both collected within the same 30 day time period (e.g. post-operative days 50-79 inclusive). All data within <figref idref="f0007">Figure 7</figref> are based on the same 30-day time window approach. Data therefore include repeated threshold and impedance measurements on each electrode. Electrode height and retinal thickness measurements were taken less frequently, but the same approach still applied; electrode height and retinal thickness estimates were compared to impedance or threshold measurements taken within the same 30 day time window as the OCT measurement.
0052As shown in <figref idref="f0007">Figure 7a</figref>, across subjects there was a significant slope (s) of -1(s =-1.0, p<0.001) between threshold and impedance. (log threshold=1/log impedance +k) on log axes. The linear regression slope on log-log axes was significantly less than zero in 5 of the 6 individual subjects (S1, s=-14.1, p<0.001; S2, s=-15.8, p<0.001; S3, s=-4.4, p<0.001; S4, s=-6.15, p<0.001;S6, s=-0.578, p<0.001).
0053As shown in <figref idref="f0007">Figure 7b</figref>, across subjects there is a positive correlation between log electrode distance from the retina and log threshold (s=2.21, p<0.001). However the slope was significantly greater than zero in only 1 of 5 of the individual subjects for which OCT data were available (S2, s=1.954, p<0.001). There was, therefore, a strong relationship between estimated electrode distance and threshold across subjects, but this correlation was not apparent within individual subjects.
0054It has been suggested that, in retinal stimulation, the electric field may diminish with the square of the distance from the electrode, as occurs in an isotropic medium with distant boundaries. If so, thresholds should increase with the square of the distance of the electrode from the retinal surface. Recent electrophyiological data do indeed find that spike thresholds increase with distance according to a square law within in vitro retinal preparations. The solid line that overlaps the best-fit dashed line shows predicted regression based on the square of the distance (the intercept was minimized using a maximum likelihood procedure).The good fit suggests that, for our array configuration, modeling the electric field current as an isotropic medium with distant boundaries may provide a reasonable model for electrical stimulation thresholds.
0055As shown in <figref idref="f0007">Figure 7c</figref>, across subjects there is negative correlation between log impedance and log electrode distance (s=-1.1, p<0.001). The linear regression slope on log-log axes was significantly less than zero in only 2 of the 5 individual subjects for which OCT data were available (S2, s=-0.08, p<0.001; S6, s=-0.3, p<0.001). Therefore there was once again a strong relationship between estimated electrode distance and impedance across subjects, but this correlation was again not clear within individual subjects.
0056As shown in <figref idref="f0007">Figure 7d</figref>, there was a very shallow but significant negative correlation between electrode distance and retinal thickness (s=-0.18, p<0.05, note that this significance level does not remain significant after correction for multiple comparisons) across subjects. One possible explanation for this weak correlation may have been that the surgeon may have been more conservative in the placement of the array in subjects whose retinal surface appeared more fragile. S5 showed a significant <i>positive</i> slope relating electrode distance from the retinal surface and retinal thickness (S5, s=1.213, p<0.01, p<0.05 after Bonferroni correction), which may have been due to a slight compression of the retinal surface by the array in this subject. Alternatively it is possible that the high currents that are necessary when there is a large distance between the array and the retina resulted in a reduction of the thickness of the retinal surface.
0057As shown in <figref idref="f0007">Figure 7e</figref>, across subjects there was no correlation between retinal thickness and impedance (p<0.05). Within the 5 individual subjects, two subjects had a shallow negative correlation (S3, s=-0.3, p<0.001; S6, s=-0.1, p<0.001) and a third showed a shallow positive correlation (S4, s=0.04, p<0.001).
0058As shown in <figref idref="f0007">Figure 7f</figref>, across subjects there was no correlation between retinal thickness and threshold (p<0.05). One subject showed a significant positive correlation (S6, s=0.4, p<0.01). These leftmost three figures (d, e, f) suggest that there was little compression of the retina by the array, and what compression there was did not have a major affect on either thresholds or impedance.
DISCUSSION
0059Consistent with the hypothesis that the high thresholds reported in previous human acute studies were due to distance between the electrode array and the retinal surface, we find that our thresholds are significantly lower than had been previously reported for human retinal electrical stimulation. Indeed, in our later subjects electrical stimulation thresholds are comparable to those reported in the animal in vitro electrophysiological literature. This suggests that retinal degeneration due to RP does not result in a significant elevation of the electrical stimulation threshold.
0060We found that thresholds were the same for 250 and 500 µm electrodes. This is in contradiction to a recent literature review by Sekirnjak et al. who found, across a wide range of in vitro and in vivo studies, that log thresholds increase linearly with log electrode area, with a slope of 0.7. However, as shown by <figref idref="f0005">Figure 5b</figref>, it is possible that a wider range of electrode sizes would make threshold differences as a function of electrode size more apparent. It is also possible, given the large electrode sizes used in this experiment that there was a "ringing" of current around electrode edges. Smaller electrodes would be expected to have more even current distribution across the electrode surface.
0061Here we simply measured threshold: the current needed for stimulation to be reliably detected. Useful prosthetic vision will, of course, require supra-threshold stimulation at higher current intensities that are needed to elicit a threshold percept. Nonetheless, thresholds provide a useful indication of the lower limit beyond which it will be difficult to reduce electrode size. Our low threshold values suggest that even without any reduction in threshold current amplitude with smaller electrodes (as would be predicted from in vitro data, see above), it may still be possible to use smaller electrodes than those used in this study provided the array is close to the retinal surface. The results from S5 and S6 (where the surgeon was more experienced with tacking the array to the retinal surface) both show thresholds consistently below 100 µA (1 ms pulse) on a majority of the electrodes. Assuming platinum has a conservative safe stimulation limit of 0.10 mC/cm<sup>2</sup>, these data imply that an electrode of just under 200 µm diameter would be acceptable. More advanced materials such as iridium oxide, with higher safe stimulation limits could safely permit an electrode of 65 µm diameter. Reducing electrode size will permit more electrodes within the same retinal area, translating into more pixels per degree of visual angle. Simulations of prosthetic vision suggest that more electrodes in the central visual area of the retina may lead to a higher resolution image and better visual task performance.
0062Our data confirms in vitro retinal electrophysiology data suggesting that the distance of electrode from the retina is a significant concern. We see a positive correlation between threshold current and electrode distance from the retina (with a slope consistent with the hypothesis that the electric field may diminish with the square of the distance from the electrode). This suggests that stimulus current requirements are likely to increase significantly as the electrode lifts off the retina, resulting in large power consumption by the stimulator and a need for significantly larger electrodes to safely supply current. A second concern is that the ability to produce small localized percepts is also likely to be compromised by large separations between electrodes and the retinal surface.
0063We see a negative correlation between electrode distance and impedance, consistent with the notion that electrodes that are flush on the surface of the retina have higher impedances (due to the adjacent retinal tissue) than electrodes that have lifted from the retina (where saline solution intervenes between the electrode and the retinal surface).
0064We believe that the distance of electrodes from the retinal surface is similarly the common factor responsible for the negative correlation between threshold and impedance. Correlations between threshold and impedance were significant in 5 out of the 6 individual subjects. We believe finding significant correlations within individual subjects between threshold and impedance but not for OCT measurements likely to be due to the fact that we had a much larger data set for impedance and threshold values (OCT data were sparse due to collection difficulties).
0065The relationship between electrode distance from the retinal surface, impedance and threshold can been seen very clearly in S2, <figref idref="f0006">Figure 6</figref>. A lifting of the array (observed using fundus imaging since OCT imaging was not available at the time) led to an increase in thresholds and a decrease in impedances. After the array was reattached impedances increased and thresholds dropped. There was then a second gradual lifting of the array from the retinal surface, which was again accompanied by an increase in thresholds and a decrease in impedance.
0066We see an initial instability in impedance values shortly after implantation and stimulation that may be analogous to the rapid changes in impedance due to changes in the tissue surrounding the electrode and electrochemical changes within the electrode that are found in cochlear implants. However, because OCT measurements were only taken at relatively infrequent intervals we cannot exclude the possibility that these changes in impedance were due to slight shifts in the position of the array as it 'settled' on the retina.
0067If long term stimulation led to retinal tissue damage or electrode corrosion we might expect to see gradual increases in thresholds and changes in impedance that were not associated with changes in the position of the array. In subjects S4 and S6 OCT measurements were taken over an extended time period during which the array remained stable. During this time period changes in threshold and impedance values tended to be relatively small (see <figref idref="f0006">Figure 6</figref>). However it is nonetheless possible that that there may be subtle postoperative changes in either the electrode surface or the retinal surface underlying the electrode that were not apparent in our data.
0068As better OCT imaging techniques become available it may be feasible, in the next generation of retinal implants, to track short term changes in electrode distance to the retina in the immediate post-operative period. Detailed information about the distance of the electrode from the retinal surface will allow a much finer characterization of the relationship between threshold, impedance and electrode position during the immediate post-implantation period.
0069Our data demonstrate that maintaining close proximity between the electrode array and the retinal surface will be critical in developing a successful retinal implant. Thinner electrode structures may maintain more stable proximity to the retina will become more tractable. With the use of electrode arrays that are stable and flush on the retinal surface, and more complex measures of perceptual performance than our simple threshold measure, it is likely that other factors such as electrode size, retinal deterioration and subject age may begin to play a more significant role.
0070Hence, the applicant has determined through experiment that, for electrical stimulation of the retina, electrodes with high impedance require less current to create the perception of a pixel of light. This relationship varies with electrode size. Impedance values may therefore provide a quick measure of the sensitivity of an electrode (i.e. the amount of current needed to elicit a percept on that electrode).
0071Impedance also varies with the height of the electrode array from the retinal surface. This means that impedance measurements can be used to estimate whether the array has shifted on the retina, and to estimate the distance of various parts of the array from the retinal surface in a less time-consuming way that direct measurements of retinal position (such as OCT).
0072Threshold varies with the height of the array from the retinal surface. Therefore, if measuring the height of each electrode from the retinal surface is possible, it is possible to estimate electrode sensitivities based on their height from the retinal surface.
0073Impedance can also vary across the retinal surface due to disease and physical irregularities. It is advantageous to provide a surgeon with real time impedance information during surgery to aid the surgeon in placing the stimulating electrode array.
0074It should also be noted that it is not always necessary to test every electrode. As array resolution becomes greater, it will become increasingly difficult to test every electrode. Geographically related electrodes tend to have similar impedance, electrode - retinal height, and threshold of perception. Hence, impedance, electrode - retinal height, and threshold of perception can be extrapolated from testing sample electrodes.
0075<figref idref="f0008">Figure 8</figref>, depicts a computer screen optimized for providing impedance information in a clear and simple manner. The screen provides a grid of dots <b>81,</b> one dot corresponding to each electrode. The dots on the computer screen are in the physical layout as the electrode array. A series of colors ranging through the color spectrum are assigned to impedance ranges and show in a key <b>82</b> to the left of the dots <b>81.</b> Each time an impedance measurement is taken, the dot corresponding to the measured electrode is colored according to the measured impedance. After the entire array of electrodes have been measured, the physician can quickly scan the hue of the screen to assess the placement of the electrodes or any areas that have higher impedance than others. This allows the surgeon to quickly asses multiple locations while implanting an electrode array. Alternatively, an audible signal where pitch is proportional to mean frequency of the electrodes may allow a surgeon to look at the array placement while receiving impedance feedback.
0076It is also advantageous to further emphasize electrodes out of acceptable range by placing an X <b>85</b> across the corresponding dot. The measurement may be continuous or activated manually by a measure impedance button <b>83</b> on the screen. An all waveforms button <b>84,</b> displays the complete stimulation wave form for analysis as described with respect to <figref idref="f0013">figure 11</figref> below. The information screen also includes information <b>86</b> on the experimenter, subject, proper communications, and if the implant is currently stimulating.
0077The implanted neural stimulator provides bidirectional data through an RF link. Stimulation information is provided to the implanted device and telemetry information including voltage drops, from which impedance is calculated, is sent back. Impedance measurement is generally conducted sub-threshold. Although stimulation may be supra-threshold, it should be low enough to not disturb the subject. A stimulation current too small to create a percept, will still return a voltage drop measurement that can be used to calculate impedance using Ohms law.
0078<figref idref="f0009">Figure 9</figref> describes the testing procedure. As stated above, the testing can be automatically repeated or activated by the press of a button. Hence the testing software first determines the mode <b>90.</b> In continuous mode the software continuously test a timer <b>92</b> for the next testing event. In manual mode, the software test for the press of the test button <b>94.</b> Either will start the test cycle. First, the electrode counter E is set to 0 <b>96,</b> and incremented <b>98.</b> Electrode E is stimulated <b>100</b> with a sub-threshold stimulation pulse. The voltage drop is measured <b>102</b> and returned to the external system <b>104.</b> If E is not equal to the total number of electrodes 106, the process is repeated until it is. Upon measuring all electrodes the software returns to check the mode again <b>90.</b>
0079<figref idref="f0010 f0011 f0012">Figure 10</figref> shows a method of identifying defective electrodes by impedance and deactivating those defective electrodes. The process begins by selecting the first electrode <b>110.</b> The selected electrode is stimulated at a predetermined current and pulse width after the best gain setting has been identified for that electrode <b>112.</b> The system then performs the following calculations <b>114:</b><maths id="math0001" num=""><math display="block"><mrow><msub><mi mathvariant="normal">R</mi><mrow><mi mathvariant="normal">S</mi><mn mathvariant="normal">1</mn></mrow></msub><mo>=</mo><mi mathvariant="normal">v</mi><mn mathvariant="normal">2</mn><mo>−</mo><msub><mi mathvariant="normal">v</mi><mn mathvariant="normal">1</mn></msub><mo>/</mo><mi mathvariant="normal">I</mi><mo>;</mo></mrow></math><img file="EP1960040B1_D0001.tif" /></maths><maths id="math0002" num=""><math display="block"><mrow><msub><mi mathvariant="normal">C</mi><mi mathvariant="normal">S</mi></msub><mo>=</mo><mfenced separators=""><mi mathvariant="normal">I</mi><mo>*</mo><mi mathvariant="normal">pulse width</mi></mfenced><mo>/</mo><msub><mi mathvariant="normal">v</mi><mn mathvariant="normal">5</mn></msub><mo>−</mo><msub><mi mathvariant="normal">v</mi><mn mathvariant="normal">2</mn></msub><mo>;</mo></mrow></math><img file="EP1960040B1_D0002.tif" /></maths><maths id="math0003" num=""><math display="block"><mrow><mi mathvariant="normal">Z</mi><mo>=</mo><mfenced separators=""><msub><mi mathvariant="normal">V</mi><mn mathvariant="normal">5</mn></msub><mo>−</mo><msub><mi mathvariant="normal">V</mi><mn mathvariant="normal">1</mn></msub></mfenced><mo>/</mo><mi mathvariant="normal">I</mi><mo>;</mo></mrow></math><img file="EP1960040B1_D0003.tif" /></maths><maths id="math0004" num=""><math display="block"><mrow><msub><mi mathvariant="normal">R</mi><mrow><mi mathvariant="normal">S</mi><mn mathvariant="normal">2</mn></mrow></msub><mo>=</mo><msub><mi mathvariant="normal">V</mi><mn mathvariant="normal">5</mn></msub><mo>−</mo><msub><mi mathvariant="normal">V</mi><mn mathvariant="normal">6</mn></msub><mo>/</mo><mi mathvariant="normal">I</mi><mn mathvariant="normal">.</mn></mrow></math><img file="EP1960040B1_D0004.tif" /></maths> f(S<sub>1</sub>, S<sub>2</sub>, S<sub>3</sub>) which can be one of a number of functions include including linearity, monotonicity, or similar function. V<sub>1-6</sub> are voltage drops taken at various points in the stimulation waveform (see <figref idref="f0013">figure 11</figref>). S1, S2, S3 are the incremental slopes of the capacitive charging portion of the voltage measurement. If R<sub>S1</sub> is less that 1.5KΩ <b>116,</b> the system calculates <b>R<sub>S2</sub> 118.</b> If R<sub>S2</sub> is less than 1.5KΩ <b>120,</b> current is doubled <b>122</b> and the best gain setting is found <b>124</b> and the electrode is stimulated again. This doubling of the measurement current is continued till it reaches the maximum charge density safety limit. When the current reaches the safety limit without a good measurement being obtained, the electrode is marked as compromised. If R<sub>S2</sub> is greater or equal to 1.5KQ, 120, R<sub>S1</sub> is set to R<sub>S2</sub><b>126.</b> If Z is greater than 45KΩ and R<sub>S1</sub> is less than 1.5KΩ <b>128</b> then the electrode is marked as compromised <b>130.</b> If not all electrodes have been tested <b>132</b> then the next electrode is selected <b>134.</b> If all electrodes have been tested <b>132,</b> the process returns to the first electrode <b>136.</b> If Z is less than 10KΩ, <b>138,</b> the electrode is marked as in the low impedance group <b>140.</b> Otherwise it is marked as in the high impedance group <b>142.</b> The system computes the median Z and standard deviation for the low impedance group <b>144</b> and the median Z and standard deviation for the high impedance group <b>146.</b> If Z for an electrode minus the median Z is greater than or equal to four times the standard deviation <b>148,</b> then calculate C<sub>S</sub> (or alternatively calculate the function of S described above and mark the electrode broken if the function pass criteria is violated) <b>150.</b> If C<sub>S</sub> is greater than 250nF <b>152,</b> the electrode is marked broken <b>154.</b> Alternatively, if an electrode is the high impedance group and Z for the electrode minus the median Z is greater than or equal to four times the standard deviation <b>156,</b> then C<sub>S</sub> is calculated (or alternatively calculate the function of S described above and mark the electrode broken if the function pass criteria is violated) <b>150</b> and if C<sub>S</sub> is greater than 250nF <b>152,</b> the electrode is marked broken <b>154.</b> Otherwise, the electrode is marked good <b>168.</b>
0080If an electrode is in the low impedance group and its Z minus the median Z is less than the negative of four times the standard deviation <b>158,</b> then calculate C<sub>S</sub> (or alternatively calculate the function of S described above and mark the electrode shorted and if the function pass criteria is violated) <b>160.</b> If CS is greater than 250nF <b>162,</b> the electrode is marked shorted <b>164.</b> Alternatively, if an electrode is the high impedance group and Z for the electrode minus the median Z is less than the negative of four standard deviations <b>166,</b> then Cs is calculated (or alternatively calculate the function of S described above and mark the electrode shorted and if the function pass criteria is violated) <b>160</b> and if C<sub>S</sub> is greater than 250nF <b>162,</b> the electrode is marked shorted <b>164.</b> Otherwise, the electrode is marked good <b>168.</b> Hence, a fully automated system can measure impedance, predict a fitting curve and identify defective electrodes without clinician intervention.
0081<figref idref="f0013">Figure 11</figref> depicts a stimulation pulse further illustrating the measurements described in <figref idref="f0010 f0011 f0012">figure 10</figref>. Points labeled one through 7 are voltage measurement points. Hence V, is the voltage drop measured at point 1. S<sub>i</sub> is the slope of the curve between V<sub>2</sub> and V<sub>3</sub>, S<sub>2</sub> is the slope of the curve between V<sub>3</sub> and V<sub>4</sub> and S<sub>3</sub> is the slope of the curve between V<sub>4</sub> and V<sub>S</sub>
Contents2
17 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17
Every citation, both ways
| Document | Relation | Office |
|---|---|---|
| WO2004052451A | Cites | World Intellectual Property Organization (WIPO) |
| WO2005000394A | Cites | World Intellectual Property Organization (WIPO) |
| WO2006116256A | Cites | World Intellectual Property Organization (WIPO) |
| US5628317A | Cites | United States of America |
| US5722403A | Cites | United States of America |
| US2002068930A1 | Cites | United States of America |
| US6293674B1 | Cites | United States of America |
46 members in 5 offices
Priority claims11
| Document | Office | Kind | Date |
|---|---|---|---|
| 74181005 | United States of America | P | |
| 741810P | United States of America | – | |
| 85347706 | United States of America | P | |
| 853477P | United States of America | – | |
| 2006046042 | United States of America | W | |
| WO2006US46042 | – | – | – |
| US20050741810P | – | – | – |
| US20060853477P | – | – | – |
| 741810P | – | – | – |
| 853477P | – | – | – |
| 2006046042 | – | – | – |
Members46
| Document | Office | Kind | |
|---|---|---|---|
| US2006184062A1 | United States of America | A1 | |
| AU2006214142A1 | Australia | A1 | |
| WO2006089155A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2006271123A1 | United States of America | A1 | |
| WO2006089155A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2007093876A1 | United States of America | A1 | |
| AU2006320425A1 | Australia | A1 | |
| WO2007064916A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2007064916A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2007191911A1 | United States of America | A1 | |
| EP1858586A2 | European Patent Office (EPO) | A2 | |
| WO2008051869A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2007064916A9 | World Intellectual Property Organization (WIPO) | A9 | |
| WO2008051869A3 | World Intellectual Property Organization (WIPO) | A3 | |
| JP2008529684A | Japan | A | |
| US2008188908A1 | United States of America | A1 | |
| EP1960040A2 | European Patent Office (EPO) | A2 | |
| US2008262569A1 | United States of America | A1 | |
| US2008262570A1 | United States of America | A1 | |
| US2008262571A1 | United States of America | A1 | |
| US2008294223A1 | United States of America | A1 | |
| US7483751B2 | United States of America | B2 | |
| US7493169B2 | United States of America | B2 | |
| US2009132004A1 | United States of America | A1 | |
| EP2091607A2 | European Patent Office (EPO) | A2 | |
| US7738962B2 | United States of America | B2 | |
| US7818064B2 | United States of America | B2 | |
| US2011015699A1 | United States of America | A1 | |
| AU2006214142B2 | Australia | B2 | |
| EP2335775A1 | European Patent Office (EPO) | A1 | |
| AU2006320425B2 | Australia | B2 | |
| US8180454B2 | United States of America | B2 | |
| US8190267B2 | United States of America | B2 | |
| US8239033B2 | United States of America | B2 | |
| US8239034B2 | United States of America | B2 | |
| US2012203293A1 | United States of America | A1 | |
| US8244363B2 | United States of America | B2 | |
| US8504162B2 | United States of America | B2 | |
| US2013304156A1 | United States of America | A1 | |
| US9078739B2 | United States of America | B2 | |
| US9084895B2 | United States of America | B2 | |
| EP1858586B1 | European Patent Office (EPO) | B1 | |
| EP1960040B1This record | European Patent Office (EPO) | B1 | |
| US9597495B2 | United States of America | B2 | |
| EP2091607B1 | European Patent Office (EPO) | B1 | |
| EP2335775B1 | European Patent Office (EPO) | B1 |
79 legal events, as 10 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Lapsed because of non-payment of the annual feeLapsedMM | MM | BE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent lapsedLapsedMM4A | MM4A | IE | |
| Patent ceasedCeasedPL | PL | CH | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| Fee paymentPLFP | PLFP | FR | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097 | R097 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Deletion acc. to par. 5 (withdrawal of the translation of the ep patent)MK05 | MK05 | AT | |
| Patent invalid in the netherlands as no translation has been filedMP | MP | NL | |
| Invalidated european patentMG4D | MG4D | LT | |
| Dpma publication of mentioned ep patent grantGrantedR096 | R096 | DE | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| Party data changed (patent owner data changed or rights of a patent transferred)RAP2 | RAP2 | EP | |
| Party data changed (patent owner data changed or rights of a patent transferred)RAP2 | RAP2 | EP | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Reference to at number (ep patent enters austrian national phase)REF | REF | AT | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Request for extension of the european patent (deleted)DAX | DAX | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1960040
- Publication, DOCDB
- 1960040
- Publication, EPODOC
- EP1960040
- Application
- 6847493
- Application, DOCDB
- 06847493
- Application, EPODOC
- EP20060847493
Titles3
- German
- EINSATZ EINER NERVENPROTHESE ÜBER IMPEDANZ UND ELEKTRODENHÖHE
- English
- FITTING A NEURAL PROSTHESIS USING IMPEDANCE AND ELECTRODE HEIGHT
- French
- INSERTION D'UNE PROTHESE NEURALE AU MOYEN DE L'IMPEDANCE ET DE LA HAUTEUR DES ELECTRODES
Classification
- CPC, 3
- A61N1/0543
- A61N1/36046
- A61N1/37247
- IPC, 3
- A61N1 05
- A61N1 36
- A61N1 372
Designated states31
- Contracting states, 31
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Hungary
- Ireland
- Iceland
- Italy
- Liechtenstein
- Lithuania
- Luxembourg
- Latvia
- Monaco
- Netherlands (Kingdom of the)
and 7 moreShow fewer
- Poland
- Portugal
- Romania
- Sweden
- Slovenia
- Slovakia
- Türkiye
